2025 Latin America Cell And Gene Therapy Manufacturing Services Market Revenue Opportunities Report
Description
The 2025 Latin America Cell And Gene Therapy Manufacturing Services Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Cell and Gene Therapy Manufacturing Services Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Cell and Gene Therapy Manufacturing Services Market in Latin America are Thermo Fisher Scientific, Lonza Group, Catalent Inc., and Terumo Blood and Cell Technologies. Thermo Fisher Scientific provides extensive global manufacturing services including in Latin America, offering process development and regulatory support. Lonza Group, a prominent global player, is also active in Latin America, supporting scaling of cell and gene therapy manufacturing. Catalent Inc., known for comprehensive biologics manufacturing, maintains a footprint in the region to cater to growing demand. Terumo BCT expands its automated manufacturing technologies in Brazil, Colombia, Mexico, and other Latin American countries, addressing local scalability and affordability challenges.
These companies leverage advanced technologies like automation and robust manufacturing platforms to enable scalable, cost-efficient production of therapies targeting unmet medical needs. Latin America’s market, projected to grow at a CAGR over 20%, is dominated by pre-clinical and clinical manufacturing segments with Brazil leading regional growth. Terumo BCT's local manufacturing facility in Costa Rica and multiple offices across Latin America illustrate the strategic commitment to this region. Collectively, these top companies offer cell collection, processing, cell therapy development, GMP manufacturing, and regulatory compliance to facilitate patient access to innovative treatments across Latin America.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Cell and Gene Therapy Manufacturing Services Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Cell and Gene Therapy Manufacturing Services Market in Latin America are Thermo Fisher Scientific, Lonza Group, Catalent Inc., and Terumo Blood and Cell Technologies. Thermo Fisher Scientific provides extensive global manufacturing services including in Latin America, offering process development and regulatory support. Lonza Group, a prominent global player, is also active in Latin America, supporting scaling of cell and gene therapy manufacturing. Catalent Inc., known for comprehensive biologics manufacturing, maintains a footprint in the region to cater to growing demand. Terumo BCT expands its automated manufacturing technologies in Brazil, Colombia, Mexico, and other Latin American countries, addressing local scalability and affordability challenges.
These companies leverage advanced technologies like automation and robust manufacturing platforms to enable scalable, cost-efficient production of therapies targeting unmet medical needs. Latin America’s market, projected to grow at a CAGR over 20%, is dominated by pre-clinical and clinical manufacturing segments with Brazil leading regional growth. Terumo BCT's local manufacturing facility in Costa Rica and multiple offices across Latin America illustrate the strategic commitment to this region. Collectively, these top companies offer cell collection, processing, cell therapy development, GMP manufacturing, and regulatory compliance to facilitate patient access to innovative treatments across Latin America.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
